Recent advances in selective serotonergic agents

被引：9

作者：

Childers, WE ^{[1
]}

Robichaud, AJ ^{[1
]}

机构：

[1] Wyeth Ayerst Res, Chem & Screening Sci, Princeton, NJ 08543 USA

来源：

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40 | 2005年 / 40卷

关键词：

D O I：

10.1016/S0065-7743(05)40002-0

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Arguably, serotonin (5-HT) is one of the most studied of the neurotransmitters. The identification of 5-HT as a vasoconstricting agent over 50 years ago [1] and the discovery that more than one subtype of 5-HT receptor exists [2] marked the beginning of a monumental effort that has extended our knowledge, not only of 5-HT receptors, but of G-protein coupled receptors (GPCR's) in general. There are presently fourteen known 5-HT receptor subtypes, some of which exist as multiple splice variants. They are located both centrally and peripherally, influence a number of physiological functions, and are implicated in many disease states [3]. Numerous reports describe ligands that bind to multiple 5-HT receptor subtypes with high affinity or agents that interact with the 5-HT uptake site. The recent literature on these pursuits is extensive and merits review in its own right. The goal of this chapter is to summarize recent advances in selective 5-HT receptor modulators [4,5]. © 2005 Elsevier Inc. All rights reserved.

引用

页码：17 / 33

页数：17

共 120 条

[1] Analysis of the role of the 5-HT1B receptor in spatial and aversive learning in the rat [J].

Åhlander-Lüttgen, M ;

Madjid, N ;

Schött, PA ;

Sandin, J ;

Ögren, SO .

NEUROPSYCHOPHARMACOLOGY, 2003, 28 (09) :1642-1655

[2] In vitro characterization of AR-A000002, a novel 5-hydroxytryptamine1B autoreceptor antagonist [J].

Ahlgren, C ;

Eriksson, A ;

Tellefors, P ;

Ross, SB ;

Stenfors, C ;

Malmberg, Å .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 499 (1-2) :67-75

[3] Molecular cloning and pharmacological characterization of the guinea pig 5-HT1E receptor [J].

Bai, F ;

Yin, TG ;

Johnstone, EM ;

Su, C ;

Varga, G ;

Little, SP ;

Nelson, DL .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 484 (2-3) :127-139

[4]

BARD JA, 1993, J BIOL CHEM, V268, P23422

[5] A review of central 5-HT receptors and their function [J].

Barnes, NM ;

Sharp, T .

NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152

[6] EMD 281014, a new selective serotonin 5-HT2A receptor antagonist [J].

Bartoszyk, GD ;

van Amsterdam, C ;

Böttcher, H ;

Seyfried, CA .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 473 (2-3) :229-230

[7] 1-(2-aminoethyl)-3-(arylsulfonyl)-1H-indoles as novel 5-HT6 receptor ligands [J].

Bernotas, R ;

Lenicek, S ;

Antane, S ;

Zhang, GM ;

Smith, D ;

Coupet, J ;

Harrison, B ;

Schechter, LE .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (22) :5499-5502

[8] 5-HT2C receptor agonists as potential drugs for the treatment of obesity [J].

Bickerdike, MJ .

CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2003, 3 (08) :885-897

[9] New 5-HT2c receptor agonists [J].

Bishop, MJ ;

Nilsson, BM .

EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (11) :1691-1705

[10] 5-HT4 Receptors [J].

Bockaert, J. ;

Claeysen, S. ;

Compan, V ;

Dumuis, A. .

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2004, 3 (01) :39-51

← 1 2 3 4 5 6 7 8 9 10 →